Sankalita Ray Das , Brett Delahunt , Annette Lasham , Kunyu Li , Deborah Wright , Cristin Print , Tania Slatter , Antony Braithwaite , Sunali Mehta
{"title":"结合 TP53 基因突变和同种异构体有望改善临床实践","authors":"Sankalita Ray Das , Brett Delahunt , Annette Lasham , Kunyu Li , Deborah Wright , Cristin Print , Tania Slatter , Antony Braithwaite , Sunali Mehta","doi":"10.1016/j.pathol.2024.02.003","DOIUrl":null,"url":null,"abstract":"<div><p>The clinical importance of assessing and combining data on <em>TP53</em> mutations and isoforms is discussed in this article. It gives a succinct overview of the structural makeup and key biological roles of the isoforms. It then provides a comprehensive summary of the roles that p53 isoforms play in cancer development, therapy response and resistance. The review provides a summary of studies demonstrating the role of p53 isoforms as potential prognostic indicators. It further provides evidence on how the presence of <em>TP53</em> mutations may affect one or more of these activities and the association of p53 isoforms with clinicopathological data in various tumour types. The review gives insight into the present diagnostic hurdles for identifying <em>TP53</em> isoforms and makes recommendations to improve their evaluation. In conclusion, this review offers suggestions for enhancing the identification and integration of <em>TP53</em> isoforms in conjunction with mutation data within the clinical context.</p></div>","PeriodicalId":19915,"journal":{"name":"Pathology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0031302524000874/pdfft?md5=f1881aa50aaa5612645bddc633d65aaf&pid=1-s2.0-S0031302524000874-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Combining TP53 mutation and isoform has the potential to improve clinical practice\",\"authors\":\"Sankalita Ray Das , Brett Delahunt , Annette Lasham , Kunyu Li , Deborah Wright , Cristin Print , Tania Slatter , Antony Braithwaite , Sunali Mehta\",\"doi\":\"10.1016/j.pathol.2024.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The clinical importance of assessing and combining data on <em>TP53</em> mutations and isoforms is discussed in this article. It gives a succinct overview of the structural makeup and key biological roles of the isoforms. It then provides a comprehensive summary of the roles that p53 isoforms play in cancer development, therapy response and resistance. The review provides a summary of studies demonstrating the role of p53 isoforms as potential prognostic indicators. It further provides evidence on how the presence of <em>TP53</em> mutations may affect one or more of these activities and the association of p53 isoforms with clinicopathological data in various tumour types. The review gives insight into the present diagnostic hurdles for identifying <em>TP53</em> isoforms and makes recommendations to improve their evaluation. In conclusion, this review offers suggestions for enhancing the identification and integration of <em>TP53</em> isoforms in conjunction with mutation data within the clinical context.</p></div>\",\"PeriodicalId\":19915,\"journal\":{\"name\":\"Pathology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0031302524000874/pdfft?md5=f1881aa50aaa5612645bddc633d65aaf&pid=1-s2.0-S0031302524000874-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0031302524000874\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0031302524000874","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
Combining TP53 mutation and isoform has the potential to improve clinical practice
The clinical importance of assessing and combining data on TP53 mutations and isoforms is discussed in this article. It gives a succinct overview of the structural makeup and key biological roles of the isoforms. It then provides a comprehensive summary of the roles that p53 isoforms play in cancer development, therapy response and resistance. The review provides a summary of studies demonstrating the role of p53 isoforms as potential prognostic indicators. It further provides evidence on how the presence of TP53 mutations may affect one or more of these activities and the association of p53 isoforms with clinicopathological data in various tumour types. The review gives insight into the present diagnostic hurdles for identifying TP53 isoforms and makes recommendations to improve their evaluation. In conclusion, this review offers suggestions for enhancing the identification and integration of TP53 isoforms in conjunction with mutation data within the clinical context.
期刊介绍:
Published by Elsevier from 2016
Pathology is the official journal of the Royal College of Pathologists of Australasia (RCPA). It is committed to publishing peer-reviewed, original articles related to the science of pathology in its broadest sense, including anatomical pathology, chemical pathology and biochemistry, cytopathology, experimental pathology, forensic pathology and morbid anatomy, genetics, haematology, immunology and immunopathology, microbiology and molecular pathology.